AstraZeneca moves up

Shares in AstraZeneca rose nearly 5% last week marking a boost for the research-based pharmaceutical industry. They will retain their monopoly in Seroquel a schizophrenia medicine, which made more than $4bn (£2bn) worldwide last year. Hopefully good news for science jobs in the UK

Posted in: News
CK Logo in place of featured image